IP Library Granted Patent US 8,026,072
Granted Patent B2
US 8,026,072 · App. 12/715,987 · Granted Sep 27, 2011

Method of identifying compounds that bind BAFF-R

Assignee: Biogen Idec MA Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,026,072
App. No.
12/715,987
Granted
Sep 27, 2011
Kind
B2
Abstract

Disclosed are nucleic acids encoding BAFF-R polypeptides, as well as antibodies to BAFF-R polypeptides and pharmaceutical compositions including the same. Methods of treating tumorigenic and autoimmune conditions using the nucleic acids, polypeptides, antibodies and pharmaceutical compositions of this invention are also provided.

Claims (3)

1. A method for identifying a compound that binds to BAFF-R comprising:

(a) contacting BAFF-R with a compound;

(b) determining whether the compound binds to BAFF-R.

Assignments (1)
CHANGE OF NAME Recorded May 4, 2015
From: BIOGEN IDEC MA INC.
To: BIOGEN MA INC.
Reel/Frame 035571/0926 →
Continuity (7)
Division 11426286 · Jun 23, 2006
Division 10380703
Provisional Application 60312185 · Aug 14, 2001
Provisional Application 60268499 · Feb 13, 2001
Provisional Application 60234140 · Sep 21, 2000
Provisional Application 60233152 · Sep 18, 2000
Related Publication 20100311189A1 · Dec 9, 2010